Difficulty: Medium
Average Score: 93%
Practice
A patient undergoing cancer chemotherapy gets ondansetron for prophylaxis of drug-induced nausea and vomiting. Which of the following best describes this drug's main mechanism of action in this setting?
Correct answer
B
Rationale
The correct answer is B) Blocks central serotonin (5-HT3) receptors. Ondansetron, a 5-HT3 receptor antagonist, is commonly used to prevent chemotherapy-induced nausea and vomiting by blocking serotonin receptors in the chemoreceptor trigger zone and the gastrointestinal tract. Serotonin plays a key role in triggering the vomiting reflex, so by blocking these receptors, ondansetron effectively reduces nausea and vomiting.
Option A is incorrect because ondansetron does not activate opioid receptors; instead, it acts on serotonin receptors. Option C is incorrect as ondansetron does not block dopamine receptors. Option D is incorrect because ondansetron does not act on histamine H1 receptors in the brainstem and inner ear.
In an educational context, understanding the mechanism of action of gastrointestinal drugs like ondansetron is crucial for healthcare professionals managing patients undergoing chemotherapy. Knowing how specific drugs work helps in selecting the most appropriate treatment to effectively manage side effects and improve patient outcomes.
Option A is incorrect because ondansetron does not activate opioid receptors; instead, it acts on serotonin receptors. Option C is incorrect as ondansetron does not block dopamine receptors. Option D is incorrect because ondansetron does not act on histamine H1 receptors in the brainstem and inner ear.
In an educational context, understanding the mechanism of action of gastrointestinal drugs like ondansetron is crucial for healthcare professionals managing patients undergoing chemotherapy. Knowing how specific drugs work helps in selecting the most appropriate treatment to effectively manage side effects and improve patient outcomes.